These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 34323701)
41. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking. Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066 [TBL] [Abstract][Full Text] [Related]
42. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment. Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628 [TBL] [Abstract][Full Text] [Related]
43. Antioxidative and therapeutic potential of selected Australian plants: A review. Mani JS; Johnson JB; Hosking H; Ashwath N; Walsh KB; Neilsen PM; Broszczak DA; Naiker M J Ethnopharmacol; 2021 Mar; 268():113580. PubMed ID: 33189842 [TBL] [Abstract][Full Text] [Related]
44. Modulation of signal transduction pathways by natural compounds in cancer. Ranjan A; Fofaria NM; Kim SH; Srivastava SK Chin J Nat Med; 2015 Oct; 13(10):730-42. PubMed ID: 26481373 [TBL] [Abstract][Full Text] [Related]
45. Anti-neoplastic Potential of Flavonoids and Polysaccharide Phytochemicals in Glioblastoma. Atiq A; Parhar I Molecules; 2020 Oct; 25(21):. PubMed ID: 33113890 [TBL] [Abstract][Full Text] [Related]
46. Glutathione peroxidase 1 activity dictates the sensitivity of glioblastoma cells to oxidative stress. Dokic I; Hartmann C; Herold-Mende C; Régnier-Vigouroux A Glia; 2012 Nov; 60(11):1785-800. PubMed ID: 22951908 [TBL] [Abstract][Full Text] [Related]
47. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. Jhaveri A; Deshpande P; Pattni B; Torchilin V J Control Release; 2018 May; 277():89-101. PubMed ID: 29522834 [TBL] [Abstract][Full Text] [Related]
48. Targeting Glioblastoma with the Use of Phytocompounds and Nanoparticles. Pistollato F; Bremer-Hoffmann S; Basso G; Cano SS; Elio I; Vergara MM; Giampieri F; Battino M Target Oncol; 2016 Feb; 11(1):1-16. PubMed ID: 26275397 [TBL] [Abstract][Full Text] [Related]
49. Oxidative Stress Modulation and ROS-Mediated Toxicity in Cancer: A Review on Vallejo MJ; Salazar L; Grijalva M Oxid Med Cell Longev; 2017; 2017():4586068. PubMed ID: 29204247 [TBL] [Abstract][Full Text] [Related]
50. Biliverdin reductase plays a crucial role in hypoxia-induced chemoresistance in human glioblastoma. Kim SS; Seong S; Lim SH; Kim SY Biochem Biophys Res Commun; 2013 Nov; 440(4):658-63. PubMed ID: 24113378 [TBL] [Abstract][Full Text] [Related]
51. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. Chikara S; Nagaprashantha LD; Singhal J; Horne D; Awasthi S; Singhal SS Cancer Lett; 2018 Jan; 413():122-134. PubMed ID: 29113871 [TBL] [Abstract][Full Text] [Related]
52. Safety and Efficacy Assessments to Take Antioxidants in Glioblastoma Therapy: From In Vitro Experiences to Animal and Clinical Studies. Turkez H; Tozlu OO; Arslan ME; Mardinoglu A Neurochem Int; 2021 Nov; 150():105168. PubMed ID: 34450218 [TBL] [Abstract][Full Text] [Related]
53. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide. Ning S; Knox SJ Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556 [TBL] [Abstract][Full Text] [Related]
54. The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy. Rajabi S; Maresca M; Yumashev AV; Choopani R; Hajimehdipoor H Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33916780 [TBL] [Abstract][Full Text] [Related]
56. Luteolin induces apoptosis by ROS/ER stress and mitochondrial dysfunction in gliomablastoma. Wang Q; Wang H; Jia Y; Pan H; Ding H Cancer Chemother Pharmacol; 2017 May; 79(5):1031-1041. PubMed ID: 28393257 [TBL] [Abstract][Full Text] [Related]
57. The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells. Bou-Gharios J; Assi S; Bahmad HF; Kharroubi H; Araji T; Chalhoub RM; Ballout F; Harati H; Fares Y; Abou-Kheir W Pharmacol Rep; 2021 Feb; 73(1):227-239. PubMed ID: 33140310 [TBL] [Abstract][Full Text] [Related]
58. Therapeutic strategies by modulating oxygen stress in cancer and inflammation. Fang J; Seki T; Maeda H Adv Drug Deliv Rev; 2009 Apr; 61(4):290-302. PubMed ID: 19249331 [TBL] [Abstract][Full Text] [Related]
59. Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro. Peigñan L; Garrido W; Segura R; Melo R; Rojas D; Cárcamo JG; San Martín R; Quezada C Neurochem Res; 2011 Aug; 36(8):1397-406. PubMed ID: 21544552 [TBL] [Abstract][Full Text] [Related]
60. The power of a novel combined anticancer therapy: challenge and opportunity of micotherapy in the treatment of Glioblastoma Multiforme. Gaiaschi L; Roda E; Favaron C; Gola F; Gabano E; Ravera M; Rossi P; Bottone MG Biomed Pharmacother; 2022 Nov; 155():113729. PubMed ID: 36166961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]